Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05990192
Title SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy (SOPRANO)
Acronym SOPRANO
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries GBR


No variant requirements are available.